Antimicrobial Drugs and Resistance; Notice of Public Meeting

Resumen

The Food and Drug Administration (FDA) is announcing a public meeting to discuss the development of drug products for the treatment of resistant bacteria, including selective spectrum agents. The purpose of the meeting is to provide information on the agency's plans for future public scientific discussions of issues unique to the development of these drug products and to invite members of the public to provide comments on the agency's plans.